|
Gilbert, Jill; Rudek, Michelle A; Higgins, Michaela J et al. (2012) A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck. Clin Cancer Res 18:1735-42
|
|
Fracasso, Paula M; Williams, Kerry J; Chen, Ronald C et al. (2011) A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies. Cancer Chemother Pharmacol 67:1225-37
|
|
Karp, Judith E; Smith, B Douglas; Resar, Linda S et al. (2011) Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias. Blood 117:3302-10
|
|
Smith, B Douglas; Jones, Richard J; Cho, Eunpi et al. (2011) Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF. Leuk Res 35:87-94
|
|
Stearns, Vered; Mori, Tsuyoshi; Jacobs, Lisa K et al. (2011) Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Sci Transl Med 3:106ra108
|
|
Bisht, Savita; Khan, Mehtab A; Bekhit, Mena et al. (2011) A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest 91:1383-95
|
|
Connolly, Roisin M; Rudek, Michelle A; Garrett-Mayer, Elizabeth et al. (2011) Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer. Breast Cancer Res Treat 127:153-62
|
|
Ray, Balmiki; Bisht, Savita; Maitra, Amarnath et al. (2011) Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease. J Alzheimers Dis 23:61-77
|
|
Weekes, Colin D; Nallapareddy, Sujatha; Rudek, Michelle A et al. (2011) Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer. Invest New Drugs 29:1057-65
|
|
Armstrong, Andrew J; Netto, George J; Rudek, Michelle A et al. (2010) A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer. Clin Cancer Res 16:3057-66
|
Showing the most recent 10 out of 29 publications
